Americann, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021
May 13, 2021 at 05:01 pm EDT
Share
AmeriCann, Inc. announced earnings results for the second quarter ended March 31, 2021. For the second quarter, the company announced total revenue was USD 437,344 compared to USD 34,690 a year ago. Operating loss was USD 36,295 compared to USD 504,120 a year ago. Net loss was USD 304,092 compared to USD 420,084 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago. For the half year, total revenue was USD 708,929 compared to USD 69,381 a year ago. Operating loss was USD 338,873 compared to operating Income of USD 713,163 a year ago. Net loss was USD 806,376 compared to net income of USD 597,901 a year ago. Basic loss per share from continuing operations was USD 0.03 compared to basic earnings per share from continuing operations of USD 0.03 a year ago.
AmeriCann, Inc. is a cannabis company that develops cultivation, processing and product manufacturing facilities. It has provisional licenses to produce cannabis-infused products, including beverages, edibles, topicals and concentrates. It designs GMP-certified cannabis extraction and product manufacturing infrastructure. Its flagship project is the Massachusetts Cannabis Center (MCC), which is being developed on a 52-acre parcel. MCC project is permitted for over 800,000 square feet of cannabis cultivation and processing infrastructure which is being developed in phases to support both the existing medical cannabis and the emerging adult-use cannabis marketplace. The Company, through a 100% owned subsidiary, AmeriCann Brands, Inc., has received two licenses from the Massachusetts Cannabis Control Commission to cultivate cannabis and provide extraction and product manufacturing support to the entire MCC project, as well as to other licensed cannabis farmers throughout regulated market.
AMERICANN, INC. 
